Indivior PLC (OTCMKTS:INVVY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Craig Hallum restated a “buy” rating and set a $50.00 target price on shares of Indivior in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Indivior has an average rating of “Buy” and an average price target of $50.00.
Read Our Latest Stock Report on Indivior
Indivior Trading Down 1.8%
About Indivior
Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing treatments for addiction and related disorders. The company’s core business centers on addressing opioid use disorder through a portfolio of branded pharmaceuticals and delivery systems designed to support long-term recovery. Indivior’s therapies are aimed at improving patient outcomes by reducing withdrawal symptoms and lowering the risk of relapse.
The company’s flagship product, Suboxone®, is a buprenorphine-naloxone sublingual film approved for the treatment of opioid dependence.
Featured Stories
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
